Rotavirus vaccination and stunting: Secondary Data Analysis from the Peruvian Demographic and Health Survey |
| |
| Institution: | 1. Mayo Clinic Vaccine Research Group, Mayo Clinic, Rochester, MN, USA;2. Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA;1. American College of Legal Medicine, Inc., Chicago, United States;2. University of Illinois College of Medicine, Chicago, Rockford, IL, United States;3. Magistrate Court of Cherokee County, GA, United States;4. Northeastern University School of Pharmacy, Boston, MA, United States;5. Clemson University, Department of Public Health Sciences, Clemson, SC, United States;6. Limestone College, Department of Health Sciences, Gaffney, SC, United States;7. Baylor University, Hankamer School of Business, Army Med. Dept., Waco, TX, United States;1. Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea;2. Division of Infectious Diseases, Chungbuk National University College of Medicine, Cheongju, Chungcheongbuk-do, Republic of Korea;3. Division of Nephrology, Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, Gangwon-do, Republic of Korea;4. Division of Infectious Disease, Department of Internal Medicine, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Republic of Korea;5. Division of Infectious Diseases, Department of Internal Medicine, Dongtan Sacred Heart Hospital , Hallym University College of Medicine, Hwasung, Republic of Korea;6. Department of Microbiology, Institute for Viral Diseases, Korea University College of Medicine, Seoul, Republic of Korea;2. Department of Microbiology and Immunology at Institute of Biomedicine, The Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden;3. Incepta Vaccine Ltd. Dewan Idris Road, Jirabo, Savar, Dhaka. Bangladesh;1. Laboratory of Virology, Microbiology, Quality, Biotechnologies/Eco-Toxicology and Biodiversity, Faculty of Sciences and Techniques, Mohammedia, University Hassan II of Casablanca, Casablanca, Morroco;2. Laboratory of Cellular and Molecular Pathologies, Faculty of Medicine and Pharmacy, University Hassan II of Casablanca, Casablanca, Morocco |
| |
| Abstract: | Rotavirus infection is the leading cause of acute diarrhea in children and is preventable with a vaccine. Malnutrition increases the risk for the development of enteric and respiratory diseases, but also diarrhea increases the risk for stunting, having a negative effect in height-for-age Z score (HAZ). Therefore, Rotavirus can be considered as one of the contributing factors to stunting. The objective was to determine if vaccination against rotavirus was associated with changes in HAZ of children aged 6–60 months. We analyzed the data of Demographic and Health Survey (DHS) 2015–2017 for Peru, which is a nationwide representative. We fitted linear regression models controlling for complex sampling. The vaccine coverage was close to 75.5%, and the mean HAZ was −0.76 standard deviations. After adjusting by demographic, health, and household characteristics, children who received rotavirus vaccine, had a mean HAZ 0.06 standard deviations higher than children who did not receive it. Additionally, BCG vaccination, a higher education level of the mother, a higher wealth index, and treating water for drinking were positively associated with HAZ. On the other hand, we found low birth weight, lack of flush toilet, and altitude higher than 2500 m above sea level negatively associated with HAZ. Rotavirus vaccine is associated with better anthropometric measurements. |
| |
| Keywords: | Rotavirus vaccines BCG vaccine Stunting Child growth |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
